A UCLA-led team has described how it advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results